← Back to Search

Gratitude Intervention for Breast Cancer

N/A
Waitlist Available
Led By Lakeshia Cousin, PhD, APRN
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 months
Awards & highlights

Study Summary

This trialwill explore how gratitude & goal-setting can improve health & well-being for Black women who have had breast cancer.

Eligible Conditions
  • Breast Cancer
  • Positive Psychology
  • Cancer Survivors
  • Exercise
  • Cardiometabolic Syndrome
  • Feasibility Studies
  • African American
  • Female

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Participant completion of baseline assessment measures
Participant completion of both baseline assessments and post-intervention assessments
Participants who met inclusion criteria compared to participants approached
+1 more
Secondary outcome measures
Change in Distress from baseline to post-intervention
Change in Exercise readiness from baseline to post-intervention
Change in Inflammatory biomarkers from baseline to post-intervention
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Gratitude InterventionExperimental Treatment1 Intervention
Each participant will receive a gratitude journal (paperback or electronic journal based on preference) for eight weeks and will have the following journaling prompt to complete at least twice a week: "There are many things in our lives, both large and small, that we might be grateful about. Think back over the day and write down on the line below all that you are grateful for today" (maximum six reasons). The educational goal-setting component will be drawn from the American Cancer Society's Nutrition, Physical Activity, and Cancer toolkit. Participants will be able to choose the order in which they complete the goal-setting modules. Both exercises will be administered daily over eight weeks.
Group II: Attention ControlActive Control1 Intervention
Each participant will receive a journal (paperback or electronic journal based on preference) Participants will receive the following general journaling prompt to complete at least twice a week: "What are some memorable events that happened to you today, big, or small (maximum six memories). Write a brief statement about it.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Gratitude Intervention
2022
N/A
~30

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor
1,340 Previous Clinical Trials
715,670 Total Patients Enrolled
14 Trials studying Breast Cancer
591 Patients Enrolled for Breast Cancer
National Institute on Aging (NIA)NIH
1,668 Previous Clinical Trials
28,005,038 Total Patients Enrolled
14 Trials studying Breast Cancer
40,449 Patients Enrolled for Breast Cancer
Lakeshia Cousin, PhD, APRNPrincipal InvestigatorUniversity of Florida

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

For what purpose is this clinical experiment being conducted?

"This clinical trial will evaluate the efficacy of participants who meet its inclusion criteria over an 8-week period. The primary outcome is to compare these individuals with those approached for involvement in the study. Secondary endpoints include changes in exercise readiness, distress level and inflammatory biomarkers from baseline measurements to post-intervention assessment points; this data shall be collected using reliable instruments such as Stage of Motivational Readiness for Physical Activity questionnaire, Perceived Stress Scale and Luminex/ELISA panel respectively."

Answered by AI

Is eligibility extended to individuals over 40 years old for this clinical research?

"Eligible participants for this trial must have a chronological age between 50 and 99 years old."

Answered by AI

Are there any openings to participate in this research experiment?

"As indicated on clinicaltrials.gov, the recruitment for this study is currently ongoing. The trial was originally posted on 8th November 2022 and information concerning it was most recently updated on 1st December 2022."

Answered by AI

Who is eligible to partake in this medical experiment?

"This study seeks 28 female applicants aged between 50 and 99 years old. To be considered, individuals must: self-identify as African American or Black; be proficient in the English language; have a past of breast cancer within 3 to 6 years post adjuvant chemotherapy treatment; those receiving hormonal therapies or HER2 therapy are qualified too."

Answered by AI

To what extent is this research project recruiting participants?

"Affirmative. The information provided on clinicaltrials.gov points to this trial as an active recruitment effort, with the initial posting being made November 8th 2022 and a recent update taking place December 1st 2022. This study seeks 28 participants across one medical centre."

Answered by AI
~11 spots leftby Apr 2025